Rational design, synthesis, and evaluation of novel polypharmacological compounds targeting NaV1.5, KV1.5, and K2P channels for atrial fibrillation
Atrial fibrillation (AF) involves electrical remodeling of the atria, with ion channels such as NaV1.5, KV1.5, and TASK-1 playing crucial roles. This study investigates acetamide-based compounds designed as multi-target inhibitors of these ion channels to address AF. Compound 6f emerged as the most...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
April 2025
|
| In: |
The journal of biological chemistry
Year: 2025, Volume: 301, Issue: 4, Pages: 1-24 |
| ISSN: | 1083-351X |
| DOI: | 10.1016/j.jbc.2025.108387 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.jbc.2025.108387 Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0021925825002364 |
| Author Notes: | Lorena Camargo-Ayala, Mauricio Bedoya, Albert Dasí, Merten Prüser, Sven Schütte, Luis Prent-Peñaloza, Francisco Adasme-Carreño, Aytug K. Kiper, Susanne Rinné, Paola Andrea Camargo-Ayala, Paula A. Peña-Martínez, Alfonso Bueno-Orovio, Diego Varela, Felix Wiedmann, José C.E. Márquez Montesinos, Yuliet Mazola, Whitney Venturini, Rafael Zúñiga, Leandro Zúñiga, Constanze Schmidt, Blanca Rodriguez, Ursula Ravens, Niels Decher, Margarita Gutiérrez, and Wendy González |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1929162529 | ||
| 003 | DE-627 | ||
| 005 | 20250913141705.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250626s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jbc.2025.108387 |2 doi | |
| 035 | |a (DE-627)1929162529 | ||
| 035 | |a (DE-599)KXP1929162529 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Camargo-Ayala, Lorena |e VerfasserIn |0 (DE-588)1369810156 |0 (DE-627)1929163193 |4 aut | |
| 245 | 1 | 0 | |a Rational design, synthesis, and evaluation of novel polypharmacological compounds targeting NaV1.5, KV1.5, and K2P channels for atrial fibrillation |c Lorena Camargo-Ayala, Mauricio Bedoya, Albert Dasí, Merten Prüser, Sven Schütte, Luis Prent-Peñaloza, Francisco Adasme-Carreño, Aytug K. Kiper, Susanne Rinné, Paola Andrea Camargo-Ayala, Paula A. Peña-Martínez, Alfonso Bueno-Orovio, Diego Varela, Felix Wiedmann, José C.E. Márquez Montesinos, Yuliet Mazola, Whitney Venturini, Rafael Zúñiga, Leandro Zúñiga, Constanze Schmidt, Blanca Rodriguez, Ursula Ravens, Niels Decher, Margarita Gutiérrez, and Wendy González |
| 246 | 3 | 3 | |a Rational design, synthesis, and evaluation of novel polypharmacological compounds targeting Na V 1.5, K V 1.5, and K 2 P channels for atrial fibrillation |
| 264 | 1 | |c April 2025 | |
| 300 | |b Illustrationen | ||
| 300 | |a 24 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Im Titel ist der Buchstabe V zweimal und die Ziffer 2 einmal tiefgestellt | ||
| 500 | |a Online veröffentlicht: 5. März 2025, Artikelversion: 16. April 2025 | ||
| 500 | |a Gesehen am 26.06.2025 | ||
| 520 | |a Atrial fibrillation (AF) involves electrical remodeling of the atria, with ion channels such as NaV1.5, KV1.5, and TASK-1 playing crucial roles. This study investigates acetamide-based compounds designed as multi-target inhibitors of these ion channels to address AF. Compound 6f emerged as the most potent in the series, demonstrating a strong inhibition of TASK-1 (IC50 ∼ 0.3 μM), a moderate inhibition of NaV1.5 (IC50 ∼ 21.2 μM) and a subtle inhibition of KV1.5 (IC50 ∼ 81.5 μM), alongside unexpected activation of TASK-4 (∼ 40% at 100 μM). Functional assays on human atrial cardiomyocytes from sinus rhythm (SR) and patients with AF revealed that 6f reduced action potential amplitude in SR (indicating NaV1.5 block), while in AF it increased action potential duration (APD), reflecting high affinity for TASK-1. Additionally, 6f caused hyperpolarization of the resting membrane potential in AF cardiomyocytes, consistent with the observed TASK-4 activation. Mathematical modeling further validated its efficacy in reducing AF burden. Pharmacokinetic analyses suggest favorable absorption and low toxicity. These findings identify 6f as a promising multi-target therapeutic candidate for AF management. | ||
| 650 | 4 | |a atrial fibrillation | |
| 650 | 4 | |a ion channels | |
| 650 | 4 | |a K1.5 | |
| 650 | 4 | |a KP channels | |
| 650 | 4 | |a multi-target inhibitors | |
| 650 | 4 | |a Na1.5 | |
| 650 | 4 | |a Polypharmacology | |
| 700 | 1 | |a Bedoya, Mauricio |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dasí, Albert |e VerfasserIn |4 aut | |
| 700 | 1 | |a Prüser, Merten |e VerfasserIn |0 (DE-588)1330987683 |0 (DE-627)1890138541 |4 aut | |
| 700 | 1 | |a Schütte, Sven |e VerfasserIn |4 aut | |
| 700 | 1 | |a Prent-Peñaloza, Luis |e VerfasserIn |4 aut | |
| 700 | 1 | |a Adasme-Carreño, Francisco |e VerfasserIn |4 aut | |
| 700 | 1 | |8 1\p |a Kiper, Aytuğ |d 1987- |e VerfasserIn |0 (DE-588)1136752897 |0 (DE-627)893543128 |0 (DE-576)490824315 |4 aut | |
| 700 | 1 | |8 2\p |a Rinné, Susanne |d 1978- |e VerfasserIn |0 (DE-588)136274609 |0 (DE-627)57846960X |0 (DE-576)30093503X |4 aut | |
| 700 | 1 | |a Camargo-Ayala, Paola Andrea |e VerfasserIn |4 aut | |
| 700 | 1 | |a Peña-Martínez, Paula A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bueno-Orovio, Alfonso |e VerfasserIn |4 aut | |
| 700 | 1 | |a Varela, Diego |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wiedmann, Felix Tobias |d 1987- |e VerfasserIn |0 (DE-588)1055852441 |0 (DE-627)792733479 |0 (DE-576)411904159 |4 aut | |
| 700 | 1 | |a Márquez Montesinos, José C. E. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mazola, Yuliet |e VerfasserIn |4 aut | |
| 700 | 1 | |a Venturini, Whitney |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zúñiga, Rafael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zúñiga, Leandro |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schmidt, Constanze |e VerfasserIn |0 (DE-588)1055852174 |0 (DE-627)792733142 |0 (DE-576)411903721 |4 aut | |
| 700 | 1 | |a Rodriguez, Blanca |e VerfasserIn |4 aut | |
| 700 | 1 | |8 3\p |a Ravens, Ursula |d 1945- |e VerfasserIn |0 (DE-588)108516764X |0 (DE-627)848850823 |0 (DE-576)456905952 |4 aut | |
| 700 | 1 | |8 4\p |a Decher, Niels |d 1970- |e VerfasserIn |0 (DE-588)12405109X |0 (DE-627)706520505 |0 (DE-576)293997438 |4 aut | |
| 700 | 1 | |a Gutiérrez, Margarita |e VerfasserIn |4 aut | |
| 700 | 1 | |a González, Wendy |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The journal of biological chemistry |d [Amsterdam] : Elsevier B.V., 1905 |g 301(2025), 4, Artikel-ID 108387, Seite 1-24 |h Online-Ressource |w (DE-627)269247025 |w (DE-600)1474604-9 |w (DE-576)077883837 |x 1083-351X |7 nnas |a Rational design, synthesis, and evaluation of novel polypharmacological compounds targeting NaV1.5, KV1.5, and K2P channels for atrial fibrillation |
| 773 | 1 | 8 | |g volume:301 |g year:2025 |g number:4 |g elocationid:108387 |g pages:1-24 |g extent:24 |a Rational design, synthesis, and evaluation of novel polypharmacological compounds targeting NaV1.5, KV1.5, and K2P channels for atrial fibrillation |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jbc.2025.108387 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.sciencedirect.com/science/article/pii/S0021925825002364 |x Verlag |z kostenfrei |3 Volltext |
| 883 | |8 1\p |a cgwrk |d 2025 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 2\p |a cgwrk |d 2025 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 3\p |a cgwrk |d 2025 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 883 | |8 4\p |a cgwrk |d 2025 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 951 | |a AR | ||
| 992 | |a 20250626 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 1055852174 |a Schmidt, Constanze |m 1055852174:Schmidt, Constanze |d 910000 |d 910100 |d 50000 |e 910000PS1055852174 |e 910100PS1055852174 |e 50000PS1055852174 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 20 | ||
| 998 | |g 1055852441 |a Wiedmann, Felix Tobias |m 1055852441:Wiedmann, Felix Tobias |d 910000 |d 910100 |e 910000PW1055852441 |e 910100PW1055852441 |k 0/910000/ |k 1/910000/910100/ |p 14 | ||
| 998 | |g 1330987683 |a Prüser, Merten |m 1330987683:Prüser, Merten |d 910000 |d 910100 |e 910000PP1330987683 |e 910100PP1330987683 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 999 | |a KXP-PPN1929162529 |e 4738640887 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"April 2025"}],"relHost":[{"recId":"269247025","name":{"displayForm":["publ. by the American Society for Biochemistry and Molecular Biology"]},"origin":[{"dateIssuedDisp":"2021-","publisher":"Elsevier B.V. ; American Soc. of Biological Chemists ; ASBMB Publications","publisherPlace":"[Amsterdam] ; Baltimore, Md. [u.a.] ; Bethesda, Md.","dateIssuedKey":"2021"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["269247025"],"issn":["1083-351X"],"zdb":["1474604-9"]},"title":[{"subtitle":"JBC","title":"The journal of biological chemistry","title_sort":"journal of biological chemistry"}],"note":["Gesehen am 19.05.2021"],"pubHistory":["1.1905/06 -"],"part":{"text":"301(2025), 4, Artikel-ID 108387, Seite 1-24","issue":"4","extent":"24","pages":"1-24","volume":"301","year":"2025"},"language":["eng"],"titleAlt":[{"title":"JBC online"},{"title":"JBC"}],"disp":"Rational design, synthesis, and evaluation of novel polypharmacological compounds targeting NaV1.5, KV1.5, and K2P channels for atrial fibrillationThe journal of biological chemistry","type":{"bibl":"periodical","media":"Online-Ressource"},"corporate":[{"display":"American Society for Biochemistry and Molecular Biology","role":"isb"}]}],"physDesc":[{"noteIll":"Illustrationen","extent":"24 S."}],"id":{"eki":["1929162529"],"doi":["10.1016/j.jbc.2025.108387"]},"title":[{"title_sort":"Rational design, synthesis, and evaluation of novel polypharmacological compounds targeting NaV1.5, KV1.5, and K2P channels for atrial fibrillation","title":"Rational design, synthesis, and evaluation of novel polypharmacological compounds targeting NaV1.5, KV1.5, and K2P channels for atrial fibrillation"}],"recId":"1929162529","person":[{"display":"Camargo-Ayala, Lorena","given":"Lorena","family":"Camargo-Ayala","role":"aut"},{"given":"Mauricio","display":"Bedoya, Mauricio","family":"Bedoya","role":"aut"},{"display":"Dasí, Albert","given":"Albert","family":"Dasí","role":"aut"},{"role":"aut","family":"Prüser","given":"Merten","display":"Prüser, Merten"},{"given":"Sven","display":"Schütte, Sven","family":"Schütte","role":"aut"},{"family":"Prent-Peñaloza","role":"aut","given":"Luis","display":"Prent-Peñaloza, Luis"},{"family":"Adasme-Carreño","role":"aut","given":"Francisco","display":"Adasme-Carreño, Francisco"},{"display":"Kiper, Aytuğ","given":"Aytuğ","role":"aut","family":"Kiper"},{"family":"Rinné","role":"aut","display":"Rinné, Susanne","given":"Susanne"},{"role":"aut","family":"Camargo-Ayala","display":"Camargo-Ayala, Paola Andrea","given":"Paola Andrea"},{"role":"aut","family":"Peña-Martínez","display":"Peña-Martínez, Paula A.","given":"Paula A."},{"family":"Bueno-Orovio","role":"aut","display":"Bueno-Orovio, Alfonso","given":"Alfonso"},{"role":"aut","family":"Varela","given":"Diego","display":"Varela, Diego"},{"display":"Wiedmann, Felix Tobias","given":"Felix Tobias","role":"aut","family":"Wiedmann"},{"role":"aut","family":"Márquez Montesinos","display":"Márquez Montesinos, José C. E.","given":"José C. E."},{"display":"Mazola, Yuliet","given":"Yuliet","family":"Mazola","role":"aut"},{"display":"Venturini, Whitney","given":"Whitney","family":"Venturini","role":"aut"},{"family":"Zúñiga","role":"aut","given":"Rafael","display":"Zúñiga, Rafael"},{"role":"aut","family":"Zúñiga","given":"Leandro","display":"Zúñiga, Leandro"},{"display":"Schmidt, Constanze","given":"Constanze","family":"Schmidt","role":"aut"},{"given":"Blanca","display":"Rodriguez, Blanca","family":"Rodriguez","role":"aut"},{"given":"Ursula","display":"Ravens, Ursula","role":"aut","family":"Ravens"},{"family":"Decher","role":"aut","given":"Niels","display":"Decher, Niels"},{"display":"Gutiérrez, Margarita","given":"Margarita","family":"Gutiérrez","role":"aut"},{"role":"aut","family":"González","given":"Wendy","display":"González, Wendy"}],"name":{"displayForm":["Lorena Camargo-Ayala, Mauricio Bedoya, Albert Dasí, Merten Prüser, Sven Schütte, Luis Prent-Peñaloza, Francisco Adasme-Carreño, Aytug K. Kiper, Susanne Rinné, Paola Andrea Camargo-Ayala, Paula A. Peña-Martínez, Alfonso Bueno-Orovio, Diego Varela, Felix Wiedmann, José C.E. Márquez Montesinos, Yuliet Mazola, Whitney Venturini, Rafael Zúñiga, Leandro Zúñiga, Constanze Schmidt, Blanca Rodriguez, Ursula Ravens, Niels Decher, Margarita Gutiérrez, and Wendy González"]},"titleAlt":[{"title":"Rational design, synthesis, and evaluation of novel polypharmacological compounds targeting Na V 1.5, K V 1.5, and K 2 P channels for atrial fibrillation"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Im Titel ist der Buchstabe V zweimal und die Ziffer 2 einmal tiefgestellt","Online veröffentlicht: 5. März 2025, Artikelversion: 16. April 2025","Gesehen am 26.06.2025"],"language":["eng"]} | ||
| SRT | |a CAMARGOAYARATIONALDE2025 | ||